Abstract
Early identification of cognitive impairment remains challenging in settings where comprehensive cognitive and clinical assessments are not available. Acoustic and linguistic features in naturalistic speech may serve as useful behavioural markers of cognitive impairment, but the value of integrating these measures with cognitive assessment remains unclear. We tested whether combining acoustic and linguistic features from one-minute speech samples with multi-domain cognitive assessment (spanning attention, language, memory and executive functions) improves classification of cognitively unimpaired individuals from those with amnestic mild cognitive impairment or early-stage Alzheimer’s Disease. Across multiple machine learning models, combining cognitive, acoustic and linguistic features yielded significantly better classification performance than models using cognitive or speech features alone (area under the curve = 0.96-0.98, both comparisons p < .05). This proof-of-concept study reveals that integrating speech-based measures with cognitive testing may improve identification of cognitive impairment, supporting the development of accessible and scalable multimodal screening tools for primary care.
Competing Interest Statement
The authors have declared no competing interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethical approval was granted by the Human Research Ethics Committees of QIMR Berghofer Medical Research Institute and The University of Queensland.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Funder Information Declared
